Literature DB >> 12768016

Varicella-zoster virus DNA in cells isolated from human trigeminal ganglia.

Myron J Levin1, Guang-Yun Cai, Michael D Manchak, Lewis I Pizer.   

Abstract

To determine the type of cell(s) that contain latent varicella-zoster virus (VZV) DNA, we prepared pure populations of neurons and satellite cells from trigeminal ganglia of 18 humans who had previously had a VZV infection. VZV DNA was present in 34 of 2,226 neurons (1.5%) and in none of 20,700 satellite cells. There was an average of 4.7 (range of 2 to 9) copies of VZV DNA per latently infected neuron. Latent VZV DNA was primarily present in large neurons, whereas the size distribution of herpes simplex virus DNA was markedly different.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12768016      PMCID： PMC156183          DOI： 10.1128/jvi.77.12.6979-6987.2003

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  31 in total

Review 1.  Neurologic complications of the reactivation of varicella-zoster virus.

Authors:  D H Gilden; B K Kleinschmidt-DeMasters; J J LaGuardia; R Mahalingam; R J Cohrs
Journal:  N Engl J Med       Date:  2000-03-02       Impact factor: 91.245

2.  Numbers of neurons and non-neuronal cells in human trigeminal ganglia.

Authors:  J J LaGuardia; R J Cohrs; D H Gilden
Journal:  Neurol Res       Date:  2000-09       Impact factor: 2.448

3.  Fractionation of neurons and satellite cells from human sensory ganglia in order to study herpesvirus latency.

Authors:  Guang-Yun Cai; Lewis I Pizer; Myron J Levin
Journal:  J Virol Methods       Date:  2002-06       Impact factor: 2.014

4.  Varicella-zoster virus gene expression in latently infected and explanted human ganglia.

Authors:  P G Kennedy; E Grinfeld; J E Bell
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

5.  Analysis of individual human trigeminal ganglia for latent herpes simplex virus type 1 and varicella-zoster virus nucleic acids using real-time PCR.

Authors:  R J Cohrs; J Randall; J Smith; D H Gilden; C Dabrowski; H van Der Keyl; R Tal-Singer
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

6.  Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia.

Authors:  R K Saiki; S Scharf; F Faloona; K B Mullis; G T Horn; H A Erlich; N Arnheim
Journal:  Science       Date:  1985-12-20       Impact factor: 47.728

7.  Quantitation of varicella-zoster virus DNA in whole blood, plasma, and serum by PCR and electrochemiluminescence.

Authors:  M D de Jong; J F Weel; T Schuurman; P M Wertheim-van Dillen; R Boom
Journal:  J Clin Microbiol       Date:  2000-07       Impact factor: 5.948

8.  Quantitation of latent varicella-zoster virus and herpes simplex virus genomes in human trigeminal ganglia.

Authors:  S R Pevenstein; R K Williams; D McChesney; E K Mont; J E Smialek; S E Straus
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

9.  Prevalence of varicella-zoster virus DNA in dissociated human trigeminal ganglion neurons and nonneuronal cells.

Authors:  J J LaGuardia; R J Cohrs; D H Gilden
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

10.  Varicella-zoster virus RNA in human trigeminal ganglia.

Authors:  R W Hyman; J R Ecker; R B Tenser
Journal:  Lancet       Date:  1983-10-08       Impact factor: 79.321
View more
  32 in total

1.  Differentiated neuroblastoma cells provide a highly efficient model for studies of productive varicella-zoster virus infection of neuronal cells.

Authors:  Jenna Christensen; Megan Steain; Barry Slobedman; Allison Abendroth
Journal:  J Virol       Date:  2011-06-01       Impact factor: 5.103

2.  Presentation and management of herpes zoster (shingles) in the geriatric population.

Authors:  Kenneth R Cohen; Rebecca L Salbu; Jerry Frank; Igor Israel
Journal:  P T       Date:  2013-04

Review 3.  Pathogenesis of varicelloviruses in primates.

Authors:  Werner J D Ouwendijk; Georges M G M Verjans
Journal:  J Pathol       Date:  2015-01       Impact factor: 7.996

Review 4.  Paradigm shifting vaccines: prophylactic vaccines against latent varicella-zoster virus infection and against HPV-associated cancer.

Authors:  Ian H Frazer; Myron J Levin
Journal:  Curr Opin Virol       Date:  2011-10       Impact factor: 7.090

Review 5.  Review: The neurobiology of varicella zoster virus infection.

Authors:  D Gilden; R Mahalingam; M A Nagel; S Pugazhenthi; R J Cohrs
Journal:  Neuropathol Appl Neurobiol       Date:  2011-08       Impact factor: 8.090

6.  Laser-capture microdissection: refining estimates of the quantity and distribution of latent herpes simplex virus 1 and varicella-zoster virus DNA in human trigeminal Ganglia at the single-cell level.

Authors:  Kening Wang; Tsz Y Lau; Melissa Morales; Erik K Mont; Stephen E Straus
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

7.  Persistent detection of varicella-zoster virus DNA in a previously healthy child after severe chickenpox.

Authors:  Mireille T M Vossen; Mi-Ran Gent; Karla M C Peters; Pauline M E Wertheim-van Dillen; Koert M Dolman; Alex van Breda; René A W van Lier; Taco W Kuijpers
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

Review 8.  Molecular characterization of varicella zoster virus in latently infected human ganglia: physical state and abundance of VZV DNA, Quantitation of viral transcripts and detection of VZV-specific proteins.

Authors:  Yevgeniy Azarkh; Don Gilden; Randall J Cohrs
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

9.  Clinical and molecular aspects of varicella zoster virus infection.

Authors:  Don Gilden; Maria A Nagel; Ravi Mahalingam; Niklaus H Mueller; Elizabeth A Brazeau; Subbiah Pugazhenthi; Randall J Cohrs
Journal:  Future Neurol       Date:  2009-01-01

Review 10.  Varicella zoster virus infection.

Authors:  Anne A Gershon; Judith Breuer; Jeffrey I Cohen; Randall J Cohrs; Michael D Gershon; Don Gilden; Charles Grose; Sophie Hambleton; Peter G E Kennedy; Michael N Oxman; Jane F Seward; Koichi Yamanishi
Journal:  Nat Rev Dis Primers       Date:  2015-07-02       Impact factor: 52.329
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.